Editas Medicine, Inc.
EDIT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650664
In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Editas Medicine, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 238
- +3 vs. Q1 2023
- Shares held
- 62.8M
- +10.4M (+19.8%) vs. Q1 2023
- Total value
- $516.8M
- +$132.8M (+34.6%) vs. Q1 2023
- New holders
- 42
- 75 more added
- Sold out
- 39
- 48 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $386.3M |
| Q1 2026 | 208 | $127.5M |
| Q4 2025 | 197 | $102.5M |
| Q3 2025 | 194 | $149.3M |
| Q2 2025 | 194 | $90.9M |
| Q1 2025 | 195 | $51.0M |
| Q4 2024 | 207 | $64.8M |
| Q3 2024 | 230 | $187.7M |
| Q2 2024 | 236 | $263.3M |
| Q1 2024 | 226 | $503.8M |
| Q4 2023 | 226 | $595.7M |
| Q3 2023 | 222 | $481.0M |
| Q2 2023 | 238 | $516.8M |
| Q1 2023 | 236 | $384.0M |
| Q4 2022 | 251 | $479.3M |
| Q3 2022 | 265 | $590.5M |
| Q2 2022 | 258 | $561.5M |
| Q1 2022 | 257 | $862.3M |
| Q4 2021 | 307 | $1.36B |
| Q3 2021 | 321 | $2.17B |
| Q2 2021 | 316 | $2.96B |
| Q1 2021 | 314 | $2.23B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Editas Medicine, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 268,467 | $2.21M | 0.00% | +14,029+5.5% | Added |
| Jane Street Group, LLC | 269,140 | $2.22M | 0.00% | +154,871+135.5% | Added |
| State of Michigan Retirement System | 273,721 | $2.25M | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 275,158 | $2.26M | 0.00% | +11,491+4.4% | Added |
| Barclays PLC | 299,286 | $2.46M | 0.00% | +24,164+8.8% | Added |
| Citadel Advisors LLC | 335,104 | $2.76M | 0.00% | −1,287,715−79.4% | Reduced |
| BNP Paribas Arbitrage, SA | 339,362 | $2.79M | 0.01% | −102,269−23.2% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 349,297 | $2.87M | 0.01% | +31,420+9.9% | Added |
| Tri Locum Partners LP | 370,877 | $3.05M | 1.14% | +370,877 | New |
| ExodusPoint Capital Management, LP | 398,091 | $3.28M | 0.04% | +373,454+1,515.8% | Added |
| Voloridge Investment Management, LLC | 407,001 | $3.35M | 0.02% | +192,692+89.9% | Added |
| Bank of America Corp | 428,133 | $3.52M | 0.00% | −513,762−54.5% | Reduced |
| PFM Health Sciences, LP | 441,170 | $3.63M | 0.15% | −599,624−57.6% | Reduced |
| Charles Schwab Investment Management Inc | 518,270 | $4.27M | 0.00% | +4,920+1.0% | Added |
| Goldman Sachs Group Inc | 602,184 | $4.96M | 0.00% | −103,872−14.7% | Reduced |
| Rafferty Asset Management, LLC | 642,191 | $5.29M | 0.03% | −42,161−6.2% | Reduced |
| Nuveen Asset Management, LLC | 685,657 | $5.64M | 0.00% | +202,691+42.0% | Added |
| Man Group plc | 740,174 | $6.09M | 0.02% | – | – |
| Northern Trust Corp | 764,109 | $6.29M | 0.00% | +94,480+14.1% | Added |
| D. E. Shaw & Co., Inc. | 786,069 | $6.47M | 0.01% | +287,279+57.6% | Added |
| Two Sigma Advisers, LP | 790,400 | $6.50M | 0.02% | −110,600−12.3% | Reduced |
| Ghisallo Capital Management LLC | 974,618 | $8.02M | 0.96% | +974,618 | New |
| Two Sigma Investments, LP | 986,420 | $8.12M | 0.02% | +277,511+39.1% | Added |
| Credit Suisse AG | 1,073,680 | $8.84M | 0.01% | +95,717+9.8% | Added |
| JPMorgan Chase & Co | 1,124,505 | $9.25M | 0.00% | −8,446−0.7% | Reduced |
| Millennium Management LLC | 1,369,822 | $11.3M | 0.01% | +85,885+6.7% | Added |
| Geode Capital Management, LLC | 1,492,823 | $12.3M | 0.00% | +41,569+2.9% | Added |
| Pictet Asset Management SA | 1,613,141 | $13.3M | 0.02% | +556,168+52.6% | Added |
| Morgan Stanley | 1,704,958 | $14.0M | 0.00% | +828,521+94.5% | Added |
| Dimensional Fund Advisors LP | 1,767,229 | $14.5M | 0.00% | +155,476+9.6% | Added |
| Woodline Partners LP | 2,749,305 | $22.6M | 0.27% | +102,685+3.9% | Added |
| Marshall Wace, LLP | 2,838,317 | $23.4M | 0.05% | +2,838,317 | New |
| Avidity Partners Management LP | 3,000,000 | $24.7M | 0.86% | +3,000,000 | New |
| Deep Track Capital, LP | 3,453,744 | $28.4M | 1.33% | +3,453,744 | New |
| State Street Corp | 6,641,679 | $54.7M | 0.00% | −1,522,512−18.6% | Reduced |
| BlackRock Inc. | 7,595,696 | $62.5M | 0.00% | +177,334+2.4% | Added |
| Vanguard Group Inc | 8,165,474 | $67.2M | 0.00% | +962,760+13.4% | Added |
| IFP Advisors, Inc | 49 | – | – | +49 | New |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −167,981−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −154,789−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −96,261−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −36,768−100.0% | Sold out |
| Hussman Strategic Advisors, Inc. | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| Elmwood Wealth Management, Inc. | 0 | $0 | 0.00% | −30,023−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −29,414−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −27,832−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −22,400−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −20,824−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −20,549−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −17,169−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −17,106−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −16,900−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −16,400−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −15,100−100.0% | Sold out |
| McGuire Investment Group, LLC | 0 | $0 | 0.00% | −14,760−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −12,370−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −11,665−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,626−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −11,429−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −10,719−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −10,522−100.0% | Sold out |
| Silicon Hills Wealth Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Orion Capital Management LLC | 0 | $0 | 0.00% | −3,750−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,526−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −1,080−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −879−100.0% | Sold out |
| Mascoma Wealth Management LLC | 0 | $0 | 0.00% | −429−100.0% | Sold out |
| Financial Avengers, Inc. | 0 | $0 | 0.00% | −318−100.0% | Sold out |
| Sittner & Nelson, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −251−100.0% | Sold out |
| GHP Investment Advisors, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| New Millennium Group LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Benjamin Edwards Inc | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Ahrens Investment Partners LLC | – | – | – | – | Not filed |